Why Do High-Protein Diets Cause Sulfur Burps on GLP-1s?

High-Protein Diets, Sulfur Burps, and GLP-1s: How the Three Can Interact

Sulfur burps happen when gut bacteria break down sulfur-containing amino acids from protein into hydrogen sulfide gas. Eating more protein, which most GLP-1 users are told to do to protect muscle, supplies more of that raw material. GLP-1 medications slow how fast your stomach empties, giving bacteria a longer window to ferment it before the gas comes back up. Neither is a malfunction on its own; combining them is the most biologically plausible explanation for why rotten-egg burps become more noticeable on these drugs, even though no single trial has measured that combined effect directly.

What's Actually Producing the Rotten-Egg Smell

The smell itself is hydrogen sulfide (H₂S), the same compound responsible for the odor of rotten eggs and sulfur hot springs. It forms when gut bacteria metabolize sulfur, some of it from dietary sulfate, some of it from the breakdown of sulfur-containing amino acids like methionine and cysteine, both concentrated in animal protein.

A 2016 review in Alimentary Pharmacology & Therapeutics on colonic protein fermentation lays out the chemistry: when protein reaches your colon rather than being fully absorbed higher up, resident bacteria ferment it, and that process raises colonic ammonia, phenol, and hydrogen sulfide concentrations.¹ The same review notes that diets higher in protein and lower in fermentable carbohydrate shift your gut microbiome toward this fermentation pattern, and that adding back oligosaccharides, resistant starch, or nonstarch polysaccharides, or trimming total protein and specifically the sulfur-containing amino acids, is what dials it back down.¹

None of this means your gut is malfunctioning. Producing some hydrogen sulfide from protein digestion is a normal, everyday metabolic event, not a disease process. The gas only becomes a noticeable, unpleasant burp when production runs ahead of how quickly it moves through and out of your system.

Why a High-Protein Diet Feeds the Reaction

Eggs, red meat, poultry, dairy, and whey protein powder are all concentrated sources of methionine and cysteine, the two sulfur-bearing amino acids gut bacteria convert into H₂S. Whey protein in particular is notably rich in cysteine.

A 2025 joint clinical advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society has proposed higher protein targets, 1.2 to 1.6 g/kg/day or a flat 80 to 120 g/day, during active weight reduction on a GLP-1, specifically to help preserve lean mass.² The same advisory sets a protein floor of 0.4 to 0.5 g/kg/day, below which muscle atrophy and functional impairments can occur, and flags sustained intake at or above 2 g/kg/day for potential adverse health effects.² Several of the advisory's 18 co-authors, including Lydia Alexander and W. Scott Butsch, disclose advisory-board or speaker relationships with Novo Nordisk and Eli Lilly, the makers of the GLP-1 drugs this guidance is written around.

That guidance exists because losing lean mass alongside fat is a real risk on these medications. A small study presented at the Endocrine Society's ENDO 2025 meeting, later published as a conference abstract, followed 39 adults with obesity for three months, 22 on semaglutide and 17 in a diet-and-lifestyle program. Among participants who lost weight, lean mass accounted for an average of 47.5% of the weight semaglutide users lost, versus 34.8% in the lifestyle group, a gap that didn't reach statistical significance (P=.19) given the small sample.³ Within the semaglutide group, older age, female sex, and lower protein intake tracked with greater muscle loss, and losing more muscle was linked to a smaller drop in HbA1c. Two study authors disclosed Novo Nordisk relationships, and one of those also disclosed Eli Lilly. This is a small, hypothesis-generating study, not proof of a fixed lean-mass ratio, but the direction lines up with the broader case for adequate protein intake during GLP-1 treatment.

That same protein intake is intended to help protect your muscle, and it's also the ingredient gut bacteria use to make hydrogen sulfide. Cutting protein to stop the burps works against the reason you're eating it in the first place.

Why GLP-1 Medications Turn Up the Effect

Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist, and tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist; both slow gastric emptying as one of several mechanisms behind the fullness and blunted post-meal blood sugar spikes these drugs produce. Per the Zepbound label, that gastric-emptying delay is largest after the first dose and diminishes with continued use, but even a temporary slowdown means protein-containing food can sit in your stomach and upper small intestine longer before moving on, giving bacteria more time to work on the sulfur amino acids before you burp.

A 2023 single-blind trial in 20 women with obesity and PCOS quantified gastric emptying directly with scintigraphy. After 12 weeks of once-weekly semaglutide 1.0 mg, four-hour gastric retention rose from about 7% at baseline to 37%, compared with 0% in the placebo group (P=.002).⁴ That's an objectively measured slowdown in stomach emptying, not just a subjective feeling of fullness.

The FDA label reflects this at the population level. In the pooled 68-week Wegovy trials (semaglutide 2.4 mg, n=2,116 vs placebo n=1,261), eructation, the clinical term for burping, was reported in 7% of Wegovy patients versus fewer than 1% on placebo.⁵ Tirzepatide's Zepbound label lists eructation at 4% on the 5 mg dose and 5% on both the 10 mg and 15 mg doses, versus 1% on placebo.⁶ Neither label breaks out how many of those burps specifically smelled of sulfur, since that detail isn't something FDA trials capture, and no trial has directly tested the combination, but slower emptying plus more available protein substrate is the most plausible shared mechanism behind both.

What Actually Helps

You don't have to choose between hitting your protein target and being miserable after meals. A few low-risk adjustments are worth trying.

Spread protein across more, smaller meals instead of one large protein-heavy sitting. A slower stomach handles a moderate protein load per meal better than a large one, and this also matches how GLP-1 users are already advised to eat.

Spread out your sulfur-heavy protein sources instead of stacking them in one sitting. Eggs, red meat, and whey protein isolate are all concentrated sources of methionine and cysteine, and a meal or shake that combines several of them at once hands bacteria a bigger dose of raw material than one that spaces them out. This isn't about avoiding eggs or meat altogether, just not piling three high-sulfur sources onto one plate.

Chew thoroughly and eat slowly. Both give your stomach more of a head start on mechanical and enzymatic digestion before food reaches bacteria-dense regions further down.

Stay hydrated throughout the day. Adequate fluid intake supports normal gut motility, which matters more than usual when gastric emptying is already running slower than baseline.

Give it time during dose increases. GI symptoms, including burping, cluster around titration steps and tend to ease over several weeks as your gut adjusts to a new dose.

Where Probiotics Fit In, and Where They Don't

No probiotic, including ours, treats or eliminates sulfur burps. Food choices and eating pace do most of the work here, not a capsule.

What a well-built gut formula can reasonably support is the environment those bacteria operate in. That's the thinking behind our own product, WonderBiotics Probiotics for Gut Health, which pairs 12 probiotic strains with a prebiotic (fructooligosaccharides) and a five-enzyme blend that includes protease. The protease is there to help break dietary protein down earlier in digestion, in the stomach and upper small intestine, before it becomes fermentation material for bacteria further down. The prebiotic fiber gives resident bacteria a carbohydrate substrate to work with alongside protein, which is the same lever the 2016 fermentation review points to for shifting bacterial metabolism away from a protein-heavy pattern.¹ One of the included strains, Bifidobacterium animalis subsp. lactis HN019, cut average whole-gut transit time from roughly 49 to 21 hours over 14 days at a dose of 17.2 billion CFU/day in a Fonterra-funded dose-response trial of adults with functional GI symptoms (within-group change, P<.001; the three-group comparison was also P<.001).⁷ We can't confirm HN019 is dosed at that same 17.2 billion CFU level in our formula, and faster transit reducing hydrogen sulfide buildup is a reasonable theoretical inference from the transit-time data, not something the trial measured directly.

HN019's trial measured gut transit time, not hydrogen sulfide levels or burping frequency, and we haven't found a published human trial, as of 2026, that tested a probiotic blend against sulfur-burp frequency as the endpoint. A few single-strain and strain-plus-enzyme products have been tested directly against gas, bloating, and burping symptom scores. In a six-week trial of Bacillus subtilis BS50 alone (a strain not included in our formula), the share of participants whose burping score improved by at least one point was 44.7% with BS50 versus 22.2% with placebo (p=.041); the study was funded and manufactured by BIO-CAT, two authors were BIO-CAT employees, and BIO-CAT filed a related patent application.⁸ An earlier, Ganeden-funded trial of a Bacillus coagulans-plus-enzyme-blend product missed statistical significance on its gas and bloating subscores (p=.118 and p=.294) while improving an overall symptom-severity score (p=.048), among numerous comparisons run without correction for multiple testing.⁹ That mixed, industry-funded record is typical of this category, not a gap unique to our formula.

WonderBiotics Probiotics for Gut Health is built for the broader role: supporting day-to-day digestive comfort and regularity alongside a higher-protein, GLP-1 routine, which is exactly the setting where sulfur burps tend to show up. It's a supporting piece of that routine, not a substitute for the food and pacing changes that target the mechanism directly.

When to Call Your Doctor Instead of Waiting It Out

Occasional sulfur burps tied to a protein-heavy meal or a recent dose increase are expected and not a reason for alarm. A different pattern deserves a call to your prescriber: burps that come with diarrhea or abdominal pain lasting more than a week or two, symptoms that started after travel or an untreated water source, or nausea and stomach pain that gets worse on an empty stomach. Those patterns can point to conditions like small intestinal bacterial overgrowth, H. pylori, or a parasitic infection, none of which resolve with diet changes alone and none of which a probiotic is built to treat.

Treat as an emergency, not a wait-and-see situation, any of the following: severe or worsening abdominal pain that radiates to your back, especially with fever, chills, or yellowing skin (possible gallbladder disease or pancreatitis)¹⁰; an inability to pass gas or stool along with worsening bloating and vomiting (possible bowel obstruction)¹¹; or confusion, fainting, or a marked drop in urination (possible severe dehydration).¹² Never adjust or stop a prescribed GLP-1 dose on your own based on GI symptoms. Talk to your prescriber, who can weigh whether what you're experiencing is within the expected range or needs a closer look.

References

1. Yao CK, Muir JG, Gibson PR. Review article: insights into colonic protein fermentation, its modulation and potential health implications. Aliment Pharmacol Ther. 2016;43(2):181-196. PMID: 26527169. DOI: 10.1111/apt.13456
2. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obes Pillars. 2025;15:100181. PMID: 40673264. PMC12304835
3. Haines MS, et al. OR09-08 Muscle Loss With Weight Loss Is Modulated by Age, Sex, and Protein Intake and May Affect Glucose Homeostasis in Adults With Obesity. Abstract presented at ENDO 2025, the Endocrine Society's annual meeting, July 2025; published in J Endocr Soc. 2025;9(Suppl 1):bvaf149.073. DOI: 10.1210/jendso/bvaf149.073
4. Jensterle M, et al. Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity. Diabetes Obes Metab. 2023;25(4):975-984. DOI: 10.1111/dom.14944
5. Wegovy (semaglutide) injection, prescribing information, Table 3. DailyMed, setid ee06186f-2aa3-4990-a760-757579d8f77b. DailyMed
6. Zepbound (tirzepatide) injection, prescribing information. DailyMed, setid 487cd7e7-434c-4925-99fa-aa80b1cc776b. DailyMed
7. Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. PMID: 21663486. PubMed
8. Garvey SM, Mah E, Blonquist TM, Kaden VN, Spears JL. The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial. Gut Microbes. 2022;14(1):2122668. PMID: 36269141. PMC9590435
9. Kalman DS, Schwartz HI, Alvarez P, et al. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol. 2009;9:85. PMID: 19922649. PMC2784472
10. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Symptoms & Causes of Pancreatitis. niddk.nih.gov/health-information/digestive-diseases/pancreatitis/symptoms-causes; Symptoms & Causes of Gallstones. niddk.nih.gov/health-information/digestive-diseases/gallstones/symptoms-causes
11. Mayo Clinic. Intestinal obstruction - Symptoms & causes. mayoclinic.org/diseases-conditions/intestinal-obstruction/symptoms-causes/syc-20351460
12. MedlinePlus. Dehydration. medlineplus.gov/ency/article/000982.htm